The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Open accessAbstract
Sexually transmitted diseases (STDs) constitute an epidemic of tremendous magnitude, with an estimated 19.7 million persons acquiring a new STD each year [1]. Reported disease rates underestimate the true burden of infection because the majority of STDs are asymptomatic and because of underreporting [2]. Sexually transmitted diseases have far-reaching public health consequences on the sexual and reproductive health of individuals, as well as the long-term health and healthcare costs to the community [3]. The accurate identification of STDs and the effective clinical management of STDs represent an important combined strategy necessary to improve reproductive health and human immunodeficiency virus (HIV) prevention efforts [4]. This is especially relevant to women, adolescents, and infants, as untreated infections frequently result in severe, long-term complications, including facilitation of HIV infection, tubal infertility, adverse pregnancy outcomes, and cancer [5–7]. For >30 years, the Centers for Disease Control and Prevention's (CDC) publication of national guidelines for management of STDs has assisted clinicians with effective guidance on the delivery of optimal STD care. The CDC STD treatment guidelines are the most widely referenced and authoritative source of information on STD treatment and prevention strategies for clinicians who evaluate persons with STDs or those at risk for STDs. The 2015 guidelines for the treatment of STDs were developed in consultation with an independent workgroup selected on the basis of their expertise in the clinical management of STDs [8]. A systematic review was performed using a Medline database evidence-based approach focusing on peer-reviewed journal articles and abstracts that became available after the publication of the 2010 STD treatment guidelines. The outcome of this literature review informed development of tables of evidence that summarized the type of study (eg, randomized controlled trial or case series), study population and setting, treatment or other interventions, outcome measures assessed, reported findings, and weaknesses and biases in study design and analysis (available at www.cdc.gov/std/tg2015/evidence.htm). This report contains 10 background articles that contain more comprehensive discussions of the evidence used as the basis for specific recommendations contained in the 2015 STD treatment guidelines. The specific background manuscripts in this supplement include comprehensive discussion regarding the prevention, evaluation, and management of various sexually transmitted infections (STIs) and syndromes that have important implications for clinical practice. Nongonococcal urethritis (NGU) is a common syndrome encountered in clinical practice and is associated with numerous etiologic agents, including Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis, herpes simplex virus, and adenovirus [9–11]. Studies on the role of Ureaplasma have been inconsistent [12, 13], whereas uncultured or fastidious organisms found in bacterial vaginosis have been associated with urethritis [14]. The spectrum of pathogens may differ between heterosexual men and men who have sex with men, as some studies suggest that sexual preference and associated sexual practices may have clinical relevance [15, 16]. However, in a significant proportion of instances, no pathogen can be identified. Current research is investigating male genitourinary microbiomes and the role of complex microbial communities related to urethritis [17]. The urethral Gram stain has been utilized as the point-of-care test to diagnose urethritis in many healthcare settings. However, based on several studies (dependent on the sampling technique), a threshold of ≥2 white blood cells per high-power field should be considered to diagnose NGU in high-risk settings [18, 19]. Due to the various organisms associated with NGU and the lack of diagnostic tools for some organisms, treatment challenges remain, especially in men with recurrent urethritis. Acute epididymitis is a clinical syndrome consisting of pain, swelling, and inflammation of the epididymis that lasts <6 weeks. Sexually transmitted acute epididymitis usually is accompanied by urethritis, which frequently is asymptomatic. Among sexually active men aged <35 years, acute epididymitis is most frequently caused by C. trachomatis or N. gonorrhoeae [20]. Acute epididymitis caused by sexually transmitted enteric organisms (eg, Escherichia coli) also occurs among men who are the insertive partner during anal intercourse. All suspected cases of acute epididymitis should be tested for C. trachomatis and for N. gonorrhoeae by nucleic acid amplification tests (NAATs). Urine bacterial culture might have a higher yield in men with sexually transmitted enteric infections and in older men with acute epididymitis caused by genitourinary bacteriuria. Selection of presumptive therapy is based on risk for chlamydia and gonorrhea and/or enteric organis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sexually Transmitted Diseases Treatment Guidelines, 2006
Skolnik, N. S. (2007) · Current Clinical Practice · doi:10.1007/978-1-59745-313-4_17 · Cited by 3,124
Fleming, D. T., & Wasserheit, J. N. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.1.3 · Cited by 2,271
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,260
Sexually Transmitted Diseases Treatment Guidelines 2002
(2002) · PsycEXTRA Dataset · doi:10.1037/e548482006-001 · Cited by 1,237
Mast, E. E., Weinbaum, C. M., Fiore, A. E., Alter, M. J., Bell, B. P., Finelli, L., Rodewald, L. E., Douglas, J. M., Janssen, R. S., & Ward, J. W. (2006) · PubMed · Cited by 1,132
Le, M., Dunne, E. F., Saraiya, M., Chesson, H. W., Curtis, C. R., Gee, J. M., Bocchini, J. A., & Unger, E. R. (2014) · PubMed · Cited by 924
The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000193 · Cited by 706
Lukehart, S. A., Hook, E. W., Baker-Zander, S. A., Collier, A. C., Critchlow, C. W., & Handsfield, H. H. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-11-855 · Cited by 603
Rolfs, R. T., Joesoef, M. R., Hendershot, E. F., Rompalo, A. M., Augenbraun, M. H., Chiu, M., Bolan, G., Johnson, S. C., French, P., Steen, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370504 · Cited by 550
Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly
Taylor-Robinson, D., & Jensen, J. S. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-11 · Cited by 537
Cited by
Peeling, R. W., Mabey, D., Kamb, M. L., Chen, X.-S., Radolf, J. D., & Benzaken, A. S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.73 · Cited by 664
Treatment of Vulvovaginal Candidiasis—An Overview of Guidelines and the Latest Treatment Methods
Satora, M., Grunwald, A., Zaremba, B., Frankowska, K., Żak, K., Tarkowski, R., & Kułak, K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165376 · Cited by 84
Joseph, R. J., Ser, H.-L., Kuai, Y.-H., Tan, L. T.-H., Arasoo, V. J. T., Letchumanan, V., Wang, L., Pusparajah, P., Goh, B.-H., Ab Mutalib, N.-S., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10060719 · Cited by 68
De Cremer, K., De Brucker, K., Staes, I., Peeters, A., Van den Driessche, F., Coenye, T., Cammue, B. P. A., & Thevissen, K. (2016) · Scientific Reports · doi:10.1038/srep27463 · Cited by 34
Nishiki, S., Arima, Y., Kanai, M., Shimuta, K., Nakayama, S.-I., & Ohnishi, M. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.05.022 · Cited by 8
Metadata
- Authors
- Workowski, K. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11-24
- Volume
- 61
- Issue
- suppl 8
- Pages
- S759-S762
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W4245249007
- Cited by
- 588
- References
- 48
- FWCI
- 34.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. https://app.cochat.ai/papers/10.1093/cid/civ771
- The paper
- Workowski, K. A. (2015). Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clinical Infectious Diseases. https://doi.org/10.1093/cid/civ771
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.